Lv11
20 积分 2024-09-11 加入
Pharmacokinetic‐pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus
5小时前
待确认
Pharmacokinetic‐pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus
6小时前
已关闭
Comprehensive analysis of adverse event profile changes with pertuzumab addition to trastuzumab‐based breast cancer therapy: Disproportionality analysis using VigiBase
6小时前
已完结
Population Pharmacokinetic Modeling of Adavosertib (AZD1775) in Patients with Solid Tumors
2天前
已完结
A novel approach for first‐in‐human dose selection using population dose–response modelling to find a minimum anticipated biological effect level
7天前
已完结
Methotrexate toxicity and glucarpidase: A call for dose optimization
16天前
已完结
Treatment of Patients with IgA Nephropathy: A call for a new paradigm
21天前
已完结
Clinical translation of microbiome research
29天前
已完结
Mutant forms of EGFR promote HER2 trafficking through efficient formation of HER2-EGFR heterodimers
1个月前
已完结
Exposure‐tumour growth inhibition modelling of brigimadlin using phase I solid tumour data to support phase II dose selection
1个月前
已完结
皖公网安备34019202002308
